Skip to main content
. 1998 Jun;36(6):1574–1577. doi: 10.1128/jcm.36.6.1574-1577.1998

FIG. 3.

FIG. 3

Seroreactivities of P4 with serum specimens (n = 6) preincubated with 0 to 10 μg/100 μl of competing peptides. P4 itself (a) and the P4 homolog derived from the C terminus of BFRF3-encoded EBV protein (b) were used as the competing peptide.